Article
Bharat Biotech applies for Phase 3 trial of intranasal Covid-19 vaccine
Rating:
0.0
Views:
85
Likes:
1
Library:
1
Bharat Biotech has submitted an application for phase 3 trials to the Drugs Controller General of India for its intranasal vaccine.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value